Isolated +15 in bone marrow: Disease-associated or a benign finding?

Leukemia Research

Volumn 39, Issue 1, 2015, Pages 72-76

  Goswami, Rashmi Shivani ^a   Liang, Cynthia S ^a   Bueso Ramos, Carlos E ^a   Hu, Shimin ^a   Goswami, Maitrayee ^a   Yin, C Cameron ^a   Lu, Gary ^a   Medeiros, L Jeffrey ^a   Tang, Guilin ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

AML; Clinical significance; Post cytotoxic therapy; Trisomy 15

Indexed keywords

CYTOTOXIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW CELL; BONE MARROW EXAMINATION; BREAST CANCER; CELL SPECIFICITY; CHROMOSOME ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLONAL SIZE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROID CELL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; FOLLOW UP; GENETIC PARAMETERS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; INTERPHASE; LARGE CELL LYMPHOMA; LYMPHOMA; LYMPHOMA CELL; MALE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MYELODYSPLASTIC SYNDROME; MYELOMA; MYELOMA CELL; PLASMACYTOMA; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; TRISOMY; TRISOMY 15; BONE MARROW; CHROMOSOME 15; CLINICAL TRIAL; GENETICS; LYMPHOCYTE; MIDDLE AGED; PATHOLOGY;

AGED; BONE MARROW; CHROMOSOMES, HUMAN, PAIR 15; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTES; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOID CELLS; TRISOMY;

EID: 84920388084     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2014.11.005     Document Type: Article

References (17)

1. Smith A., Watson N., Sharma P. Frequency of trisomy 15 and loss of the Y chromosome in adult leukemia. Cancer Genet Cytogenet 1999, 114(2):108-111.
2. Hanson C.A., Steensma D.P., Hodnefield J.M., Nguyen P.L., Hoyer J.D., Viswanatha D.S., et al. Isolated trisomy 15: a clonal chromosome abnormality in bone marrow with doubtful hematologic significance. Am J Clin Pathol 2008, 129(3):478-485.
3. Morel F., Le Bris M.J., Herry A., Morice P., De Braekeleer M. Trisomy 15 as the sole abnormality in myelodysplastic syndromes: case report and review of the literature. Leuk Lymphoma 2003, 44(3):549-551.
4. Baumgartner B.J., Shurafa M., Terebelo H., Tapazoglou E., Van Dyke D.L. Trisomy 15, sex chromosome loss, and hematological malignancy. Cancer Genet Cytogenet 2000, 117(2):132-135.
5. Sinclair E.J., Potter A.M., Watmore A.E., Fitchett M., Ross F. Trisomy 15 associated with loss of the Y chromosome in bone marrow: a possible new aging effect. Cancer Genet Cytogenet 1998, 105(1):20-23.
6. Smith S.R., Rowe D. Trisomy 15 in hematological malignancies: six cases and review of the literature. Cancer Genet Cytogenet 1996, 89(1):27-30.
7. Sashida G., Tauchi T., Kimura Y., Ohyashiki K. Trisomy 15 as a single autosomal abnormality in a patient with unclassifiable myelodysplastic syndromes. Cancer Genet Cytogenet 2001, 127(1):91-92.
8. Batanian J.R., Slovak M.L., Mohamed A., Dobin S., Luthardt F.W., Keitges E.A. Trisomy 15 is frequently observed as a minor clone in patients with Anemia/MDS/NHL and as a major clone in patients with AML. Cancer Genet Cytogenet 2000, 121(2):186-189.
9. Reddy K.S., Sbeiti A. Trisomy 15 in hematological disorders. Cancer Genet Cytogenet 2000, 116(2):176-177.
10. Shaffer L.G., McGowan-Jordan J., Schmid M. An international system for human cytogenetic nomenclature (2013). Recommendations of the international standing committee on human cytogenetic nomenclature 2013, S. Karger, Basel.
11. Wang S.A., Hutchinson L., Tang G., Chen S.S., Miron P.M., Huh Y.O., et al. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components. Am J Hematol 2013, 88(3):219-224.
12. Tang G., Wang S.A., Lu V., Lee H.C., Qazilbash M.H., Wang X.I., et al. Clinically silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasms. Leuk Res 2014, 38(8):896-900.
13. Knapp R.H., Dewald G.W., Pierre R.V. Cytogenetic studies in 174 consecutive patients with preleukaemic or myelodysplastic syndromes. Mayo Clin Proc 1985, 60:507-516.
14. WHO classification of tumours of haematopoietic and lymphoid tissues 2008, International Agency for Research on Cancer, Lyon. S.H.C.E. Swerdlow, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein (Eds.).
15. Klimek V.M. Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia. Curr Opin Hematol 2013, 20(2):137-143.
16. Vadlamani I., Ma E., Brink D.S., Batanian J.R. Trisomy 15 in a case of pediatric hemangiopericytoma and review of the literature. Cancer Genet Cytogenet 2002, 138(2):116-119.
17. Estey E.H. Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 2012, 87(1):89-99.